|Articles|December 29, 2015

State of the healthcare industry survey results

Here's how more than 600 healthcare executives responded to questions related to reimbursement, pharmaceuticals, consumerism, consolidation, technology, and more.

State of the Industry Survey Results

Here's how more than 600 healthcare executives responded to questions related to reimbursement, pharmaceuticals, consumerism, consolidation, technology, and more.

Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Latest CME

Video

26th Annual International Lung Cancer Congress

Roy S. Herbst, MD, PhD; Sandip Patel, MD, FASCO; Heather A. Wakelee, MD, FASCO

State of the healthcare industry survey results

Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.

Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.

Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.

Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.

Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.

Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.

Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.

Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.

Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.

Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.

Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.

Newsletter

Related Content

Sonye Danoff, M.D., Ph.D., Discusses the FIBRONEER Study for IPF

Current Guideline Definitions of Barrett’s Esophagus May Fall Short in Detecting Esophageal Cancers

Navigating Female Sexuality in Midlife Requires Provider Nuance and Patient Advocacy

Tackling Health Inequities Through Collaboration and Community-Based Care

Optimal Physical Activity for Preventing Digestive System Cancers

Latest CME

26th Annual International Lung Cancer Congress

Virtual Tumor Board for the Onco-Nurse: Improving Outcomes in SCLC Treatment and AE Management

Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies

Transforming Treatment in Small Cell Lung Cancer: How Recent Trials Are Shaping Treatment Decision-Making and Future Therapies

Community Oncology Connections™: DLL3-Targeting Bispecific Antibodies for Small Cell Lung Cancer – From Innovation to Practice | Louisiana

Community Oncology Connections™: DLL3-Targeting Bispecific Antibodies for Small Cell Lung Cancer – From Innovation to Practice | Montana and Wyoming

Burst CME™: Advanced Diagnostic and Testing Approaches for Mutation-Targetable Management of NSCLC

2nd Annual Hawaii Cancer Conference

From Clue to Care: Rapid Recognition and Coordinated Management of Paraneoplastic LEMS in SCLC

Burst CME™: Exploring Diagnosis and Testing Innovations for Targetable Mutations in SCLC

Burst CME™: Addressing Diagnostic Challenges and Identifying Targets for Treatment in LCNEC-L

Inaugural Brain & Spine Metastases Conference: Evolving Practice and Emerging Therapies

23rd Annual Winter Lung Cancer Conference®

Community Practice Connections™: 19th Annual New York Lung Cancers Symposium®

Burst CME™: The Role of HER2 in NSCLC and Implications for Emerging Treatment Strategies

Future Directions in Treating SCLC and LCNEC-L: The Impact of DLL3

42nd Annual CFS: Chemotherapy Foundation Symposium®: Innovative Cancer Therapy for Tomorrow

A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One

Striking the Right Nerve: Managing Cancer Associated LEMS in Lung Cancer Patients

3rd Annual Hawaii Lung: A Multidisciplinary Case-Based Conference

Community Practice Connections™: Incorporating Recent Updates in the Treatment of Metastatic ALK-Positive NSCLC

Virtual Testing Board: Digging Deeper on Your Testing Reports to Elevate Patient Outcomes in Advanced Non–Small Cell Lung Cancer

Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies

Cases & Conversations™: Expert Perspectives on Leveraging Recent Advances to Transform SCLC Treatment

22nd Annual Winter Lung Cancer Conference®

Show Me Your Care Plan!™ Insights for Oncology Nurses on Comprehensive SCLC Treatment and Care Strategies

Show Me Your Care Plan!™ Insights for Oncology Nurses on Comprehensive SCLC Treatment and Care Strategies

(CME Credit) Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

PER Tumor Board®: Applying Recent Advances to Transform the Treatment Paradigm in SCLC—Expert Perspectives on New Approvals and Emerging Strategies

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Medical Crossfire®: The Precision Path for HER2 and TROP2-Targeted Treatments in Non–Small Cell Lung Cancer

Medical Crossfire®: DLL3-Driven Innovations in Small Cell Lung Cancer – How Do Experts Apply Pivotal Advances to Practice?

27th Annual International Lung Cancer Congress®

Breaking Down the Latest Clinical Data for First-line Maintenance and R/R SCLC

Practical Considerations and Future Directions for New Treatment Strategies in SCLC

Navigating Treatment Gaps in SCLC: Relapse, Resistance, and Need for New Options

Community Practice Connections™: Distinguishing Precision Pathways for c-Met and MET Alterations in NSCLC

A New Era of Targeted Therapy for Advanced NSCLC: Exploring Future Directions for Bispecific Antibodies and ADCs

Advances in Managing EGFR-Mutant NSCLC: Applying Evidence Across the Disease Continuum

26th Annual International Lung Cancer Congress

20th Annual New York Lung Cancers Symposium®

Trending on Managed Healthcare Executive

Tubeless AID Systems Boost HRQoL in Type 1 Diabetes

Current Guideline Definitions of Barrett’s Esophagus May Fall Short in Detecting Esophageal Cancers

Navigating Female Sexuality in Midlife Requires Provider Nuance and Patient Advocacy

Optimal Physical Activity for Preventing Digestive System Cancers

Modeling Finds the Timing of Modafinil to Treat Narcolepsy Matters for Efficacy